Financhill
Sell
30

TXN Quote, Financials, Valuation and Earnings

Last price:
$191.32
Seasonality move :
8.55%
Day range:
$186.03 - $190.42
52-week range:
$155.46 - $220.39
Dividend yield:
2.77%
P/E ratio:
35.34x
P/S ratio:
11.11x
P/B ratio:
10.04x
Volume:
4.1M
Avg. volume:
6.2M
1-year change:
13.02%
Market cap:
$173.4B
Revenue:
$17.5B
EPS (TTM):
$5.38
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $14.4B $14.5B $18.3B $20B $17.5B
Revenue Growth (YoY) -8.88% 0.54% 26.85% 9.18% -12.53%
 
Cost of Revenues $5.2B $5.2B $6B $6.3B $6.5B
Gross Profit $9.2B $9.3B $12.4B $13.8B $11B
Gross Profit Margin 63.71% 64.1% 67.47% 68.76% 62.9%
 
R&D Expenses $1.5B $1.5B $1.6B $1.7B $1.9B
Selling, General & Admin $1.6B $1.6B $1.7B $1.7B $1.8B
Other Inc / (Exp) -$77M $91M -$53M -$151M $440M
Operating Expenses $3.2B $3.2B $3.2B $3.4B $3.7B
Operating Income $6B $6.1B $9.2B $10.4B $7.3B
 
Net Interest Expenses $170M $190M $184M $214M $353M
EBT. Incl. Unusual Items $5.7B $6B $8.9B $10B $7.4B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $711M $422M $1.2B $1.3B $908M
Net Income to Company $5B $5.6B $7.8B $8.7B $6.5B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $5B $5.6B $7.8B $8.7B $6.5B
 
Basic EPS (Cont. Ops) $5.33 $6.05 $8.38 $9.51 $7.13
Diluted EPS (Cont. Ops) $5.24 $5.97 $8.26 $9.41 $7.07
Weighted Average Basic Share $936M $921M $923M $916M $908M
Weighted Average Diluted Share $952M $933M $936M $926M $916M
 
EBITDA $6.9B $7.2B $10.1B $11.2B $9B
EBIT $5.9B $6.2B $9.1B $10.2B $7.8B
 
Revenue (Reported) $14.4B $14.5B $18.3B $20B $17.5B
Operating Income (Reported) $6B $6.1B $9.2B $10.4B $7.3B
Operating Income (Adjusted) $5.9B $6.2B $9.1B $10.2B $7.8B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $3.8B $4.6B $5.2B $4.5B $4.2B
Revenue Growth (YoY) 1.22% 21.64% 12.88% -13.53% -8.41%
 
Cost of Revenues $1.4B $1.5B $1.6B $1.7B $1.7B
Gross Profit $2.5B $3.2B $3.6B $2.8B $2.5B
Gross Profit Margin 64.27% 67.89% 69.01% 62.11% 59.6%
 
R&D Expenses $386M $388M $431M $471M $492M
Selling, General & Admin $407M $412M $431M $452M $428M
Other Inc / (Exp) -$24M -$32M -$44M $128M $131M
Operating Expenses $793M $800M $862M $923M $920M
Operating Income $1.7B $2.4B $2.8B $1.9B $1.6B
 
Net Interest Expenses $49M $45M $53M $98M $131M
EBT. Incl. Unusual Items $1.6B $2.3B $2.7B $1.9B $1.6B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $234M $328M $363M $213M $192M
Net Income to Company $1.4B $1.9B $2.3B $1.7B $1.4B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $1.4B $1.9B $2.3B $1.7B $1.4B
 
Basic EPS (Cont. Ops) $1.47 $2.10 $2.50 $1.87 $1.48
Diluted EPS (Cont. Ops) $1.45 $2.07 $2.47 $1.85 $1.47
Weighted Average Basic Share $917M $923M $913M $908M $913M
Weighted Average Diluted Share $929M $936M $923M $916M $920M
 
EBITDA $1.9B $2.6B $3B $2.3B $2.1B
EBIT $1.6B $2.3B $2.7B $2B $1.7B
 
Revenue (Reported) $3.8B $4.6B $5.2B $4.5B $4.2B
Operating Income (Reported) $1.7B $2.4B $2.8B $1.9B $1.6B
Operating Income (Adjusted) $1.6B $2.3B $2.7B $2B $1.7B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $13.7B $17.6B $20.2B $18.1B $15.7B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $5B $5.9B $6.2B $6.4B $6.5B
Gross Profit $8.7B $11.7B $14B $11.7B $9.2B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $1.5B $1.6B $1.6B $1.8B $1.9B
Selling, General & Admin $1.6B $1.7B $1.7B $1.8B $1.8B
Other Inc / (Exp) -$21M $107M -$199M $330M $621M
Operating Expenses $3.2B $3.2B $3.3B $3.7B $3.7B
Operating Income $5.6B $8.5B $10.7B $8B $5.5B
 
Net Interest Expenses $187M $183M $203M $315M $476M
EBT. Incl. Unusual Items $5.3B $8.4B $10.3B $8B $5.6B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $370M $1.1B $1.4B $936M $677M
Net Income to Company $5B $7.3B $8.9B $7.1B $5B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $5B $7.3B $8.9B $7.1B $5B
 
Basic EPS (Cont. Ops) $5.37 $7.91 $9.66 $7.80 $5.43
Diluted EPS (Cont. Ops) $5.29 $7.79 $9.54 $7.70 $5.38
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $6.5B $9.6B $11.5B $9.5B $7.6B
EBIT $5.5B $8.6B $10.5B $8.4B $6.1B
 
Revenue (Reported) $13.7B $17.6B $20.2B $18.1B $15.7B
Operating Income (Reported) $5.6B $8.5B $10.7B $8B $5.5B
Operating Income (Adjusted) $5.5B $8.6B $10.5B $8.4B $6.1B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $10.4B $13.5B $15.4B $13.4B $11.6B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $3.8B $4.5B $4.7B $4.9B $4.9B
Gross Profit $6.6B $9B $10.7B $8.6B $6.8B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $1.1B $1.2B $1.2B $1.4B $1.5B
Selling, General & Admin $1.2B $1.3B $1.3B $1.4B $1.3B
Other Inc / (Exp) -$24M -$8M -$154M $327M $508M
Operating Expenses $2.4B $2.4B $2.5B $2.8B $2.8B
Operating Income $4.3B $6.6B $8.2B $5.8B $4B
 
Net Interest Expenses $142M $135M $154M $255M $378M
EBT. Incl. Unusual Items $4.1B $6.5B $7.9B $5.9B $4.1B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $183M $825M $1.1B $731M $500M
Net Income to Company $3.9B $5.6B $6.8B $5.1B $3.6B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $3.9B $5.6B $6.8B $5.1B $3.6B
 
Basic EPS (Cont. Ops) $4.22 $6.07 $7.35 $5.63 $3.92
Diluted EPS (Cont. Ops) $4.17 $5.99 $7.27 $5.57 $3.89
Weighted Average Basic Share $2.8B $2.8B $2.8B $2.7B $2.7B
Weighted Average Diluted Share $2.8B $2.8B $2.8B $2.7B $2.8B
 
EBITDA $5B $7.3B $8.7B $7B $5.6B
EBIT $4.2B $6.6B $8B $6.1B $4.5B
 
Revenue (Reported) $10.4B $13.5B $15.4B $13.4B $11.6B
Operating Income (Reported) $4.3B $6.6B $8.2B $5.8B $4B
Operating Income (Adjusted) $4.2B $6.6B $8B $6.1B $4.5B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $2.4B $3.1B $4.6B $3.1B $3B
Short Term Investments $3B $3.5B $5.1B $6B $5.6B
Accounts Receivable, Net $1.1B $1.4B $1.7B $1.9B $1.8B
Inventory $2B $2B $1.9B $2.8B $4B
Prepaid Expenses -- -- -- -- --
Other Current Assets $299M $302M $335M $302M $264M
Total Current Assets $8.8B $10.2B $13.7B $14B $15.1B
 
Property Plant And Equipment $3.3B $3.3B $5.1B $6.9B $10B
Long-Term Investments $300M -- -- -- --
Goodwill $4.4B $4.4B $4.4B $4.4B $4.4B
Other Intangibles $409M $122M $85M $152M $223M
Other Long-Term Assets $468M $770M $748M $740M $853M
Total Assets $18B $19.4B $24.7B $27.2B $32.3B
 
Accounts Payable $388M $415M $571M $851M $802M
Accrued Expenses $475M $524M $82M $191M $341M
Current Portion Of Long-Term Debt $500M $550M $500M $500M $599M
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- $520M $455M $570M
Total Current Liabilities $2.1B $2.4B $2.6B $3B $3.3B
 
Long-Term Debt $5.3B $6.2B $7.2B $8.2B $10.6B
Capital Leases -- -- -- -- --
Total Liabilities $9.1B $10.2B $11.3B $12.6B $15.5B
 
Common Stock $1.7B $1.7B $1.7B $1.7B $1.7B
Other Common Equity Adj -$347M -$360M -$157M -$254M -$205M
Common Equity $8.9B $9.2B $13.3B $14.6B $16.9B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $8.9B $9.2B $13.3B $14.6B $16.9B
 
Total Liabilities and Equity $18B $19.4B $24.7B $27.2B $32.3B
Cash and Short Terms $5.4B $6.6B $9.7B $9.1B $8.6B
Total Debt $5.8B $6.8B $7.7B $8.7B $11.2B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $2.8B $5.7B $3.2B $2.6B $2.6B
Short Term Investments $2.7B $4.1B $5.9B $6.4B $6.2B
Accounts Receivable, Net $1.4B $1.7B $2B $2B $1.9B
Inventory $2.1B $1.9B $2.4B $3.9B $4.3B
Prepaid Expenses -- -- -- -- --
Other Current Assets $277M $287M $238M $265M $341M
Total Current Assets $9.3B $13.6B $13.8B $15.1B $15.9B
 
Property Plant And Equipment $3.2B $4B $6.5B $9.3B $12.6B
Long-Term Investments $47M -- -- -- --
Goodwill $4.4B $4.4B $4.4B $4.4B $4.4B
Other Intangibles $322M $97M $75M $138M $229M
Other Long-Term Assets $501M $647M $799M $1.9B $325M
Total Assets $18.2B $23.3B $26.1B $31.6B $35.3B
 
Accounts Payable $411M $596M $780M $713M $794M
Accrued Expenses $524M $551M $734M $824M $1B
Current Portion Of Long-Term Debt $550M $500M $499M $300M $1B
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $2.2B $2.4B $2.8B $2.7B $3.7B
 
Long-Term Debt $6.2B $7.2B $7.4B $10.9B $12.8B
Capital Leases -- -- -- -- --
Total Liabilities $9.9B $11.1B $11.6B $15B $18.1B
 
Common Stock $1.7B $1.7B $1.7B $1.7B $1.7B
Other Common Equity Adj -$335M -$313M -$154M -$235M -$195M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $8.3B $12.2B $14.5B $16.6B $17.3B
 
Total Liabilities and Equity $18.2B $23.3B $26.1B $31.6B $35.3B
Cash and Short Terms $5.5B $9.8B $9.1B $8.9B $8.8B
Total Debt $6.8B $7.7B $7.9B $11.2B $13.9B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $5B $5.6B $7.8B $8.7B $6.5B
Depreciation & Amoritzation $1.1B $992M $954M $979M $1.2B
Stock-Based Compensation $217M $224M $230M $289M $362M
Change in Accounts Receivable $133M -$340M -$287M -$194M $108M
Change in Inventories $216M $46M $45M -$847M -$1.2B
Cash From Operations $6.6B $6.1B $8.8B $8.7B $6.4B
 
Capital Expenditures $847M $649M $2.5B $2.8B $5.1B
Cash Acquisitions -- -- -- -- --
Cash From Investing -$1.9B -$922M -$4.1B -$3.6B -$4.4B
 
Dividends Paid (Ex Special Dividend) -$3B -$3.4B -$3.9B -$4.3B -$4.6B
Special Dividend Paid
Long-Term Debt Issued $1.5B $1.5B $1.5B $1.5B $3B
Long-Term Debt Repaid -$750M -$500M -$550M -$500M -$500M
Repurchase of Common Stock -$3B -$2.6B -$527M -$3.6B -$293M
Other Financing Activities -$42M -$36M -$46M -$41M -$57M
Cash From Financing -$4.7B -$4.5B -$3.1B -$6.7B -$2.1B
 
Beginning Cash (CF) $2.4B $2.4B $3.1B $4.6B $3.1B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$1M $670M $1.5B -$1.6B -$86M
Ending Cash (CF) $2.4B $3.1B $4.6B $3.1B $3B
 
Levered Free Cash Flow $5.8B $5.5B $6.3B $5.9B $1.3B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $1.4B $1.9B $2.3B $1.7B $1.4B
Depreciation & Amoritzation $250M $253M $262M $320M $402M
Stock-Based Compensation $50M $50M $68M $79M $87M
Change in Accounts Receivable -$216M -$62M $150M -$20M -$151M
Change in Inventories $64M -$13M -$205M -$179M -$190M
Cash From Operations $1.4B $2.4B $2.8B $1.9B $1.7B
 
Capital Expenditures $146M $486M $790M $1.5B $1.3B
Cash Acquisitions -- -- -- -- --
Cash From Investing -$2.2B -$884M -$2.1B -$1.7B -$487M
 
Dividends Paid (Ex Special Dividend) -$825M -$942M -$1.1B -$1.1B -$1.2B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $1.5B $695M -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -$15M -$139M -$996M -$46M -$318M
Other Financing Activities -$9M -$19M -$12M -$12M -$8M
Cash From Financing -$726M $470M -$1.3B -$1.1B -$1.4B
 
Beginning Cash (CF) $4.3B $3.6B $3.8B $3.4B $2.7B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$1.5B $2B -$633M -$873M -$151M
Ending Cash (CF) $2.8B $5.7B $3.2B $2.6B $2.6B
 
Levered Free Cash Flow $1.3B $1.9B $2B $442M $416M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $5B $7.3B $8.9B $7.1B $5B
Depreciation & Amoritzation $999M $984M $929M $1.2B $1.5B
Stock-Based Compensation $223M $222M $277M $356M $377M
Change in Accounts Receivable -$50M -$261M -$387M $64M $114M
Change in Inventories -$32M $209M -$541M -$1.5B -$388M
Cash From Operations $5.8B $8.5B $9B $6.5B $6.2B
 
Capital Expenditures $600M $1.4B $3.1B $4.9B $4.8B
Cash Acquisitions -- -- -- -- --
Cash From Investing -$1.8B -$2.9B -$4.8B -$5.1B -$4.1B
 
Dividends Paid (Ex Special Dividend) -$3.3B -$3.8B -$4.2B -$4.5B -$4.7B
Special Dividend Paid
Long-Term Debt Issued $1.5B -- $695M $3.8B $3B
Long-Term Debt Repaid -$500M -$550M -- -- --
Repurchase of Common Stock -$3B -$400M -$2.9B -$1.1B -$457M
Other Financing Activities -$37M -$44M -$37M -$55M -$56M
Cash From Financing -$5B -$2.8B -$6.7B -$2.1B -$2.1B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$1.1B $2.8B -$2.5B -$603M $23M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $5.2B $7.1B $5.9B $1.6B $1.5B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $3.9B $5.6B $6.8B $5.1B $3.6B
Depreciation & Amoritzation $749M $741M $716M $901M $1.1B
Stock-Based Compensation $182M $180M $227M $294M $309M
Change in Accounts Receivable -$318M -$239M -$339M -$81M -$75M
Change in Inventories -$71M $92M -$494M -$1.2B -$297M
Cash From Operations $4B $6.4B $6.7B $4.5B $4.3B
 
Capital Expenditures $437M $1.2B $1.8B $3.9B $3.6B
Cash Acquisitions -- -- -- -- --
Cash From Investing $74M -$1.9B -$2.6B -$4.1B -$3.8B
 
Dividends Paid (Ex Special Dividend) -$2.5B -$2.8B -$3.2B -$3.4B -$3.6B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $1.5B $1.5B $695M $3B $3B
Long-Term Debt Repaid -$500M -$550M -$500M -$500M -$300M
Repurchase of Common Stock -$2.5B -$385M -$2.8B -$228M -$392M
Other Financing Activities -$30M -$38M -$29M -$43M -$42M
Cash From Financing -$3.7B -$2B -$5.6B -$929M -$879M
 
Beginning Cash (CF) $9.2B $9.2B $11.9B $11B $8.2B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $385M $2.6B -$1.5B -$484M -$375M
Ending Cash (CF) $9.6B $11.8B $10.5B $10.5B $7.8B
 
Levered Free Cash Flow $3.6B $5.2B $4.8B $573M $692M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Alphabet an Undervalued Growth Stock to Buy?
Is Alphabet an Undervalued Growth Stock to Buy?

Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…

Is Tesla Going to Buy Uber?
Is Tesla Going to Buy Uber?

Tesla has always been in the habit of making large,…

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

If you want to invest in an AI-leading tech company,…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 42x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Sell
40
MSTR alert for Dec 24

MicroStrategy [MSTR] is up 8.05% over the past day.

Sell
26
NUTX alert for Dec 24

Nutex Health [NUTX] is down 0.76% over the past day.

Sell
48
VRNA alert for Dec 24

Verona Pharma PLC [VRNA] is down 0.62% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock